Clinical Trial

Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease

Name: Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease — clinical trial record (NCT07398287)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Ment-ILD

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to assess the effect of L-menthol on breathlessness and exercise capacity in patients with Interstitial lung disease (ILD).

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-25

Trial Details

NCT Number	NCT07398287
Lead Sponsor	Region Skane Collaborators: Blekinge Institute of Technology, Blekingesjukhuset, Karlskrona, Lund University
Conditions	Interstitial Lung Disease (ILD)
Enrollment	20 participants
Start Date	2026-04-13
Primary Completion	2027-02 (estimated)
Study Completion	2027-05 (estimated)
Updated on ClinicalTrials.gov	2026-04-24